Krsnaa Diagnostics: BSE Grants In-Principle Approval for Warrant Issue

Krsnaa Diagnostics Ltd has received the corrected in-principle approval letter from BSE Limited for the issuance of 16,21,000 convertible warrants to its Promoter and Promoter Group. These warrants are convertible into equity shares at an issue price of Rs. 566/- each. This approval follows an earlier intimation regarding the receipt of in-principle approval from both BSE and NSE. The company has been advised by BSE to strengthen internal controls and obtain undertakings from allottees to prevent intra-day trading and ensure compliance with SEBI regulations. The company must also ensure listing application is made within twenty days from the date of allotment.